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Summary. Chlamydia pneumoniae is a Gram-negative, obligate intracellular pathogen that causes community-acquired 
respiratory infections. After C. pneumoniae invades host cells, it disturbs the vesicle transport system to escape host lysosomal 
or autophagosomal degradation. By using a yeast mis-sorting assay, we found 10 C. pneumoniae candidate genes involved in 
aberrant vesicular trafficking in host cells. One of the candidate genes, CPj0783, was recognized by antibodies from C. pneumo­
niae-infected patients. The expression of CPj0783 was detected at mid to late-cycle time points and increased during the 
inclusion maturation. Two-hybrid screening in yeast cells revealed that CPj0783 interacted with Huntingtin-interacting protein 
14 (HIP14). The specific interaction between CPj0783 and HIP14 could be demonstrated by an in vivo co-immunoprecipitation 
assay and an in vitro GST pull-down assay. It was also demonstrated that HIP14 was localized in the Golgi apparatus and 
colocalized with CPj0783. HIP14 has a palmitoyl transferase activity that is involved in the palmitoylation-dependent vesicular 
trafficking of several acylated proteins. These findings suggest that CPj0783 might cause abnormal vesicle-mediated transport 
by interacting with HIP14. [Int Microbiol 18(4):225-233 (2015)]
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Introduction
Chlamydia pneumoniae is an obligate intracellular pathogen 
that causes acute and chronic respiratory infections in 
humans. Almost all humans face the possibility of contracting 
C. pneumoniae infections at least once in their lifetime [9]. 
Chlamydia species have a unique biphasic life cycle initiated 
by the attachment of the elementary body (EB) to the host 
cell. Then, the EB is endocytosed by the cell and is contained 
within a plasma membrane-derived vesicle, which is quickly 
modified by the pathogen to establish a replicative form, 
termed the inclusion [9]. The pathogen remains within the 
inclusion for the duration of its intracellular development 
and is transformed into the reticulate body (RB) [11]. While 
Chlamydia grows in the inclusion, the pathogen should 
escape from phagosomal degradation in host cells. It is thus 
currently thought to achieve such purposes by expressing 
certain molecules that inhibit phagosomal maturation and 
modulate the host-vesicle trafficking pathways. Previously, 
we reported the functional high-throughput screening system 
in yeast cells [20]. It has been found that the carboxypeptidase 
Y-invertase (CPY-Inv) reporter system is a powerful tool to 
identify the molecules that alter eukaryotic vesicle trafficking 
pathways. By using a similar expression screening system, 
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it has been reported that several molecules expressed by 
intracellular pathogens such as Legionella pneumoniae inhibit 
the maturation of the phagosome and/or exit the endocytic 
pathway [4,17].
We have determined the sequence of the whole genome 
of C. pneumoniae J138 strain [16] and found that this strain 
features a putative protein coded by its 1069 open reading 
frames (ORFs). A comprehensive bioinformatics approach 
has been applied for annotation taxonomy, and approximately 
half of the predicted ORFs have been found to encode 
proteins without any known functions. To identify novel 
C. pneumoniae molecules that determine virulence and 
pathogenicity, we screened 455 ORFs without any known 
functions in a yeast expression system. Here, we address the 
newly identified C. pneumoniae CPj0783 gene that causes 
mis-sorting in yeast cells. CPj0783 was found to interact 
with Huntingtin-interacting protein 14 (HIP14) in vivo and in 
vitro. HIP14 is classified in both the palmitoyl acyl transferase 
protein family (PAT family) and ankyrin repeat superfamily 
(ANK superfamily) [15,18]. HIP14 is most notably involved 
in the palmitoylation and trafficking of multiple proteins 
and has been localized to the Golgi apparatus [12,18]. The 
expression of HIP14 has been detected ubiquitously in 
human tissues and one of the most essential target proteins 
is huntingtin (HTT) [15]. Our study suggests that a novel C. 
pneumoniae molecule, CPj0783, would interact with HIP14 
and could cause aberrant vesicle trafficking.
Materials and methods
Cell culture and infection. Chlamydia pneumoniae J138 was pro pagated 
in HEp-2 cells maintained in Dulbecco’s Modified Eagle Medium (Sigma-
Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum.
Mis-sorting assay in yeast cells. We previously developed a 
carboxypeptidase Y (CPY)-invertase (Inv) reporter system in yeast cells 
[20]. The mis-sorting assay was performed using this system, as previously 
described [20]. Yeast cultures were spotted on SC-Ura/fructose with and 
without 20 µg/ml of doxycycline and grown for 2 days at 30°C. In the 
invertase overlay assay, the plates were overlaid with a 0.75% agarose 
solution containing 125 mM sucrose, 100 mM sodium acetate buffer (pH 5.5), 
0.5 mM N-ethylmaleimide, 10 µg/ml of horseradish peroxidase, 8 units/ml of 
glucose oxidase and 2 mM O-dianisidine. After 5–15 min, photographs were 
taken with a Nikon D70 digital single-lens reflex camera. Image contrast was 
adjusted using Adobe Photoshop CS6 (Adobe Systems, San Jose, CA, USA)
Protein expression and purification. For the purification of the 
glutathione S-transferase (GST)-tagged CPj0783 (25–262 amino acids) 
fusion protein, E. coli JM109 cells transformed with protein-expression 
plasmids were grown in Luria broth with 100 μg/ml ampicillin at 37°C to an 
OD600 of 0.8; then, recombinant GST gene expression was induced by the 
addition of isopropyl-1-thio-β-d-galactopyranoside to a final concentration 
of 0.3 mM at 37°C for 3 h. Cells were pelleted, resuspended in TNE buffer 
containing 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 2% NP-
40 and 1 mM phenylmethylsulfonyl fluoride and disrupted by sonication. 
Lysates were cleared by centrifugation at 20,000 ×g for 15 min at 4°C, and 
GST-tagged proteins were purified from the supernatant using glutathione-
Sepharose 4B beads. After incubation with Sepharose beads for 2 h, the beads 
were washed five times with TNE buffer, and then the recombinant fusion 
proteins were eluted with 10 mM reduced glutathione and 50 mM Tris-HCl 
at pH 9.0.
Antibodies. Antibody generation was performed as previously described 
[19]. Briefly, maltose-binding protein-tagged CPj0783 was purified on 
amylose resin and used to immunize Japanese white rabbits. The affinity-
purified anti-CPj0783 polyclonal antibody (pAb) was purified from antiserum 
on a HiTrap N-hydroxysuccinimide activated column (GE Healthcare 
Japan) coupled with GST-tagged CPj0783. HRP-conjugated goat anti-
human IgA (Monosan, Netherland), anti-human IgG and anti-human IgM 
(Invitrogen, CA) immunoglobulins were used as the secondary antibodies. 
HRP-conjugated anti-mouse and anti-rabbit IgGs were purchased from Cell 
Signaling technology (Danvers, MA, USA). Most other general reagents 
were purchased from Wako Chemicals, Nacalai Tesque and Sigma.
Immunofluorescence microscopy. Cells grown on glass coverslips 
were fixed with 4% paraformaldehyde and permeabilized with 0.05% Triton 
X-100 in PBS. Cells were incubated with primary antibodies overnight at 
4°C. Secondary antibodies coupled to Alexa 594 were incubated at room 
temperature. on cells for 60 min. The coverslips were washed and mounted 
on slides with VECTASHIELD (Vector Laboratories). Images were obtained 
using a Zeiss LSM 700 confocal laser-scanning microscope system or an 
Olympus BX53 fluorescence microscope.
Yeast two-hybrid assays and α-galactosidase activation 
assays. The yeast two-hybrid assay was performed as described in the 
Matchmaker protocol (Takara Bio Co., Japan). As a bait plasmid, the amino 
acids 25–262 of CPj0783 were cloned into the GAL4 DNA-binding domain 
expression vector. As a prey, the Mate & Plate Library-HeLa S3 (normalized) 
cDNA library was used. To assess α-galactosidase activity in isolated yeast 
transformants, colorimetric assays were performed as described in the 
manuscript provided by Takara Bio Co. 
GST pull-down assay. GST-CPj0783 was incubated with the protein 
extract from GFP-HIP14 expressing HEp-2 cells at 4°C for 2 h. The 
suspension of glutathione-Sepharose 4B beads was added, and the incubation 
was continued for an additional 30 min. The beads were washed five times, 
and extracted proteins were analyzed by immunoblotting.
Results
Chlamydia pneumoniae molecules and protein 
mis-sorting in yeast cells. It was found that the CPY-
Inv reporter system is a powerful tool to identify molecules 
that alter eukaryotic vesicle trafficking pathways [17]. Vacuole 
protein sorting gene 4 (Vps4) is one of the core proteins which 
form multivesicular bodies. When Vps4E233Q was expressed 
in yeast cells, normal endosomal function was perturbed and 
the CPY-Inv fusion protein was exported out of the cells to the 
cell surface [17,20]. Then, the media color changed to brown 
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as invertase reacted with its substrate in the overlaid agarose 
and subsequently formed brown precipitates. By using this 
system, 455 C. pneumoniae ORFs were screened and we 
consequently obtained 10 positive clones (Fig. 1). When each 
one of the CPj0186, 0572 and 1027 was expressed in yeast 
cells, they showed strong colorimetric changes in the overlay 
by the mis-sorting of CPY-Inv. When one of the other seven 
C. pneu moniae ORFs, CPj0783, 0938, 0939, 0995, 0996, 1003 
and 1005, was expressed in yeast cells, it showed moderate 
colorimetric change in the overlay. We summarized the ORF 
names, predicted amino acid length, and their orthologs in the 
C. trachomatis genome in Fig. 1B. CPj1027 did not have any 
counterpart in the C. trachomatis genome and was one of the 
C. pneumoniae specific ORFs. 
Chlamydia pneumoniae molecule expression 
in infected patients. We made a genomic screening 
system for C. pneumoniae-specific antigen molecules in the 
previous study [21] and adapted it to these candidate ORFs 
in the present study. GFP-tagged ORFs encoded by the ten 
candidates were expressed in yeast cells as described [21]. 
Serum samples were collected from eight patients (age 
range 4–11 years) who had been clinically diagnosed with 
primary acute C. pneumoniae infection. These samples were 
applied to immunoblot analyses as primary antibodies. Three 
different classes of immunoglobulins (HRP-conjugated 
anti-human IgA, IgG and IgM) were used as the secondary 
antibodies. The serum samples from these patients did not 
contain significant anti-Saccharomyces cerevisiae antibodies, 
which would have produced a high level background on the 
immunoblots (Fig. 2). Therefore, we were able to specifically 
detect the C. pneumoniae antigens under conditions of low-
level background. Then, it was revealed that CPj0783 was 
recognized by all classes of immunoglobulins examined in this 
study (Fig. 2). When antisera obtained from babies without C. 
pneumoniae infection who were diagnosed by commercially 
available serologic ELISA test kits were used for immunoblot 
analysis, we could not obtain any specific signals on the 
blots (data not shown). These results provide the evidence 
that CPj0783 had been definitely produced in patients with 
primary C. pneumoniae-infection and was recognized by the 
host immune systems. CPj0783 was no longer the candidate 
ORF but a gene undoubtedly working in its genome. Thus, we 
investigated CPj0783 in details. 
Expression of Chlamydia pneumoniae  CPj0783 
dur ing inclusion maturation. Chlamydia pneumoniae 
has a unique life cycle and two developmental stages, the 
elementary body (EB) and the reticulate body (RB). EB is 







Fig. 1. Chlamydia pneumoniae molecular 
screening using a yeast mis-sorting assay. (A) 
455 function-unknown C. pneumoniae genes 
were cloned into a CEN P
Tet-off
 vector and then 
expressed in yeast cells. The yeast was spotted 
on the induction media. The detail method of 
mis-sorting assay is described in the section 
of materials and methods. Ten C. pneumoniae 
molecules that caused mis-sorting in yeast cells 
were obtained from this screening. The candidate 
genes were analyzed in three independent 
experiments. (B) Ten C. pneumoniae molecules. 
Nine of these molecules have C. trachomatis 
orthologs, and CPj1027 was specific to C. pneu­
moniae.
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cells (infection time: 0–2 h), C. pneumoniae makes inclusion 
bodies and changes its morphology from EB to RB (2–18 h). 
RBs are the non-infectious intracellular form, yet they are 
the metabolically active replicating form. They can then 
replicate themselves through binary fission (18–48 h). After 
division, the RBs become EBs (48–72 h). We investigated at 
which stage of the chlamydial developmental cycle CPj0783 
was expressed in C. pneumoniae-infected cells. mRNA and 
protein expression were examined in C. pneumoniae-infected 
cells. Figure 3A shows that the mRNAs of C. pneumoniae 
major outer membrane protein (MOMP) and CPj0783 were 
detected by RT-PCR in C. pneumoniae-infected cells at 48 
h post-infection. Then we investigated at which stage of the 
chlamydial developmental cycle CPj0783 was expressed 
in C. pneumoniae-infected cells. The protein expression of 
MOMP was detected at 12 h post-infection, and its expression 
level increased during the developmental cycle (Fig. 
3B). According to the MOMP expression levels, bacteria 
proliferated with the longer incubation period, whereas the 
protein expression of CPj0783 was detected at 24 h to 66 h 
post-infection, and a rapid decrease in the CPj0783 expression 
after 60 h post-infection was observed. 
We investigated CPj0783 expression by immunostaining 
at 48 h post-infection (Fig. 3C). Chlamydia pneumoniae-
infected cells were analyzed by staining with DAPI and an 
antibody against CPj0783. DAPI staining clearly showed 
host cell nuclei and a chlamydial inclusion in the host-cell 
cytoplasm. Some immunoreactive punctate patterns of 
CPj0783 expression on a chlamydial inclusion were visualized 
by staining with the antibody.
CPj0783-HIP14 interaction in yeast two-
hybrid screening. To identify protein(s) that interact 
with CPj0783, a two-hybrid screening system in yeast cells 
was used in the present study. According to the predicted 
structure of CPj0783, CPj0783 might contain a putative 
transmembrane region in its N-terminus (Fig. 4A). Therefore, 
we used amino acids 25–262 of CPj0783 as a bait protein for 
yeast two-hybrid screening. Two of the positive clones were 
sequenced, and these clones were identified as part of HIP14 
and encompassed amino acids 8–182 which contained the 
ankyrin repeat domain (Fig. 4A). To confirm the results of 
a yeast two-hybrid screening, CPj0783 and the cDNA in the 
bait and prey in the initial screening were exchanged with 
each other (Fig. 4B), and then an interaction between the bait 
amino acids 8–182 of HIP14 and the prey amino acids 25–262 
of CPj0783 was detected as well (Fig. 4B). HIP14 has five 
ankyrin repeats in its N-terminal half and six transmembrane 
domains in its C-terminal half [15]. The clones obtained 
from the initial screening contained three ankyrin repeats, 
and therefore we used amino acids 1–303 of HIP14 that 
corresponded to the entire cytoplasmic region as prey. The 
resulting plasmid DNAs were transformed into haploid 
yeast to detect protein-protein interactions. An interaction 
between CPj0783 and amino acids 1–303 of HIP14, as well 
as an interaction between CPj0783 and amino acids 1–182 of 
HIP14, was detected (Fig. 4C). These results suggest that an 
interaction between CPj0783 and HIP14 in yeast cells could 
be demonstrated in this way. It was therefore important to 
clarify the interaction between CPj0783 and HIP14 in other 
ways, as described below. 
CPj0783 interaction with HIP14 in vivo. To reveal 
the interaction between CPj0783 and HIP14 in mammalian 
cells, we made mCherry-tagged CPj0783 and GFP-tagged 
HIP14 and co-transfected them into HEp-2 cells. The cell 
lysates were precipitated with anti-mCherry pAb-protein G 
beads and analyzed by immunoblotting with anti-GFP pAb. 
HIP14-GFP was specifically detected in the immunoprecipitate 







Fig. 2. CPj0783 expression in C. pneumoniae-infected patients. Serum 
samples were collected from eight patients (age range 4–11 years) who had 
been clinically diagnosed with a primary acute C. pneumoniae infection. 
Yeast cells were transformed with the amino acids 25–262 of CPj0783 
C-terminally fused to GFP (CPj0783-GFP), and then the protein was 
extracted. The predicted molecular mass of CPj0783-GFP was 56 kDa 
(arrowhead). Immunoblot analysis was performed using serum samples as 
the primary antibodies and three different classes of immunoglobulins (HRP-
conjugated anti-human IgA, IgG, IgM) as the secondary antibodies. The 
arrowheads indicate the specific band of CPj0783-GFP that was detected by 
patient sera or anti-GFP pAb (α-GFP).
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We observed the multiple mCherry-CPj0783 bands on the 
immunoblot. These multiple bands were detected not only 
by the anti-mCherry pAb but also by the anti-CPj0783 pAb. 
mCherry-CPj0783 might be an unstable protein and was 
cleaved by an unknown mechanism.
CPj0783 colocalization with HIP14 in the Golgi 
apparatus. We analyzed the subcellular localization of 
CPj0783 in HEp-2 cells. mCherry-CPj0783 and HIP14-GFP 
were co-transfected in HEp-2 cells. HIP14-GFP completely 
colocalized with a Golgi marker (Fig. 5B), as previously 
reported [7]. The location of CPj0783 clearly corresponded 
with that of HIP14-GFP. These results suggested that 
CPj0783 and HIP14 might interact with each other in the 
Golgi apparatus of mammalian cells.
CPj0783 interaction with HIP14 in vitro. To 
confirm the results of the co-immunoprecipitation assay (Fig. 
5A) and the immunostaining study (Fig. 5B), a GST pull-
down assay was performed. We made GST fusion proteins 
including the amino acids 25–262 of CPj0783 and purified 
these recombinant proteins from Escherichia coli. When the 
protein from HEp-2 cells expressing HIP14-GFP was mixed 
with GST-CPj0783, HIP14 was pulled down by CPj0783 and 
was specifically detected on the immunoblots (Fig. 5C). These 
results demonstrated that CPj0783 specifically interacted with 
HIP14 in vitro.
Discussion
Chlamydia pneumoniae is an obligate intracellular pathogen. 
It is necessary for C. pneumoniae to escape the host immune 
response. Upon infection, the nascent inclusion membrane 
surrounding the infectious EB is plasma membrane-derived, 
but within a few hours, chlamydial translocated proteins 
modify the inclusion membrane. These modifications result in 







Fig. 3. CPj0783 mRNA and protein expression in C. 
pneumoniae-infected cells. (A) HEp-2 cells were infected 
with C. pneumoniae and incubated at 37°C for 48 h. Cells 
were lysed in Sepasol-RNA I Super for the extraction 
of total RNA. RNA was treated with DNase I to remove 
DNA contamination. RNA was reverse-transcribed in 
three independent experiments. cDNA was amplified using 
primers specific for CPj0783, MOMP or α-tubulin. (B) HEp-
2 cells were infected with C. pneumoniae and incubated at 
37°C for the indicated time. Cells were lysed in TNE buffer 
for the extraction of proteins. CPj0783 or MOMP protein 
expression was analyzed by immunoblotting with specific 
antibodies. The experiments were performed in triplicate. 
(C) HEp-2 cells grown on glass coverslips were infected 
with C. pneumoniae and incubated at 37°C for 48 h. Cells 
were fixed with 4% paraformaldehyde and permeabilized 
with 0.05% Triton X-100 in PBS. Cells were incubated with 
α-CPj0783 pAb overnight at 4°C. A secondary antibody 
coupled to Alexa 594 was incubated on cells for 60 min at 
room temperature. Images were obtained using an Olympus 
BX53 fluorescence microscope.
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the separation of the inclusion from the classical endosomal/
lysosomal pathway [10]. However, the detailed mechanism 
of how Chlamydia could disturb vesicle trafficking in 
host cells remained unclear. We used the properties of a 
hybrid protein resulting from a fusion (CPY-Inv) between 
carboxypeptidase Y (CPY) and invertase (Inv), both of which 
are originally encoded by the yeast genome in nature. The 
CPY gene encodes a vacuolar hydrolase that undergoes post-
translational modifications in the Golgi apparatus, followed 
by trafficking to the late endosome and sorting to the vacuole, 
which functions as the lysosome in yeast cells. The CPY-Inv 
fusion protein is normally translocated from the endoplasmic 
reticulum to the Golgi apparatus and subsequently to the 
vacuole via the late endosome. The fusion protein is strictly 
sequestered in the vacuole and cannot reach the yeast cell 
surface at all. Thus, the cell cannot hydrolyze exogenously 
provided sucrose in this screening system. Once the normal 
trafficking becomes perturbed, cargo vesicles are blocked 
from getting to the vacuole and then mis-sorting of the fusion 
protein is induced. As a consequence, spillover of the fusion 
proteins is evoked, and they are translocated into vesicles 
destined for the yeast cell surface. When abnormal secretion 
of the fusion protein occurs in yeast cells, it allows the cell 
to hydrolyze exogenous sucrose [17,20]. In this study, we 
found ten C. pneumoniae candidate molecules that caused 
the mis-sorting of the CPY-Inv fusion protein in yeast cells. 
One of these candidates, CPj0186, showed relatively strong 
colorimetric changes in the assay system for the mis-sorting 
phenotype. It had been previously reported that CPj0186 is 
inclusion membrane protein A (IncA) and has similarity to 
CT119 in the C. trachomatis genome [2]. The IncA protein of 







Fig. 4. Identification of CPj0783-binding proteins by a yeast 
two-hybrid screen. (A) The predicted structures of CPj0783 
and HIP14. The schematic presentation of HIP14 shows its five 
ankyrin repeats, six transmembrane regions and one DHHC 
palmitoyl acyl transferase domain. Amino acids 25–262 of 
CPj0783 were cloned into the vector containing the GAL4 
DNA-binding domain (bait vector). As prey, Mate & Plate 
Library-HeLa S3 (normalized) cDNA library was used. After 
mating, yeast were grown on both SD/-Trp/-Leu and SD/-Trp/-
Leu/-His/-Ade + X-gal selection medium and incubated at 30°C 
for 48 h. The vector served as a negative control, and p53 and 
T7 served as positive controls, as suggested in the instruction 
manual. (B) To confirm the yeast two-hybrid screening results, 
the cDNAs in the baits and preys used in the screening were 
exchanged. Amino acids 8–182 of HIP14 were cloned into the 
bait vector and amino acids 25–262 of CPj0783 were cloned into 
the prey vector. The expression of recombinant HIP14 (amino 
acids 8–182) in the bait vector and CPj0783 (amino acids 
25–262) in the prey vector was confirmed by immunoblotting. 
(C) The interaction between CPj0783 and the total cytoplasmic 
region of HIP14 was examined. Amino acids 1–303 of HIP14 
were cloned into a prey vector. Expression of recombinant 
HIP14 (amino acids 1–303) in the prey vector and CPj0783 
(amino acids 25–262) in the bait vector were confirmed by 
immunoblotting.
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that IncA interacts with eukaryotic proteins called SNAREs 
(soluble N-ethylmaleimide-sensitive factor attachment protein 
receptors) that catalyze membrane fusion during intracellular 
vesicular transport [14]. We have previously reported that 
CPj0572 is recognized by three types of immunoglobulins, 
IgA, IgM and IgG, derived from hosts who suffer from 
primary acute C. pneumoniae infection [21]. In the present 
study, CPj0572 showed relatively strong colorimetric changes 
in this screening system and could be one of the candidates. 
It has been reported that CPj0572 is an ortholog molecule of 
C. trachomatis translocated actin recruiting phosphoprotein 
(Tarp), containing the alpha helix structure that is associated 
with host actin, and could actually induce actin nucleation 
[3,8]. Therefore we could accurately detect CPj0186/IncA 
and CPj0572/Tarp as molecules that caused the CPY mis-
sorting in this screening system, and this indicated that the 
system itself was functioning extremely well to identify the 
molecules altering vesicle trafficking pathways. Another 
Fig. 5. CPj0783 interaction with HIP14 in vivo and in vitro. 
(A) mCherry-CPj0783 and HIP14-GFP were expressed in 
HEp-2 cells. The proteins were extracted in TNE buffer. The 
samples were incubated with a protein G-Sepharose slurry 
to preclear the sample of nonspecific binding to proteins. 
Co-immunoprecipitation studies were carried out with these 
samples. The precipitates were analyzed by immunoblotting 
with anti-GFP pAb. Similar results were obtained from at least 
three independent experiments. (B) mCherry-CPj0783 and 
HIP14-GFP were transfected in HEp-2 cells and incubated at 
37°C for 48 h. Cells were fixed with 4% paraformaldehyde and 
permeabilized with 0.05% Triton X-100 in PBS. Cells were 
incubated with anti-P230 or GM130 mAb 594 was incubated 
at room temperature for 60 min. A secondary antibody coupled 
to Alexa 594 was incubated on cells at room temperature for 
60 min. Images were obtained using a Zeiss LSM 700 confocal 
laser-scanning microscope system. (C) GST pull-down assay. 
GST-CPj0783 was expressed in E. coli JM109. Purified GST-
CPj0783 was mixed with the crude extract obtained from 
HEp-2 cells expressing HIP14-GFP and precipitated with 
glutathione-Sepharose 4B beads. Eluates from the beads were 
subjected to SDS-PAGE and analyzed by immunoblotting 
with anti-GFP pAb. Similar results were obtained from at least 
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candidate molecule, CPj1027, which showed a strong 
colorimetric change in this assay system, has been reported 
to be a newly identified inclusion membrane protein unique 
to C. pneumoniae [5]. The CPj1027 protein was detected as 
early as 12 h after C. pneumoniae infection and remained in 
the inclusion membrane throughout the infection cycle. The 
function of CPj1027 has not yet been clarified. CPj1027 
might interact with some proteins that are related to vesicle 
trafficking. It is thus necessary to investigate the function of 
this molecule in future studies.
CPj0783 showed a moderate colorimetric change for 
the mis-sorting phenotype. The C. trachomatis ortholog of 
CPj0783 is CT598; the functions of CPj0783 and CT598 are 
completely unknown. The amino acid sequence similarity 
between CPj0783 and CT598 is merely 35%, and both 
molecules might have the similar function. CT598 is a 
hypothetical protein and its expression in C. trachomatis has 
not been proved yet. Analysis of CT598 would be necessary 
and we plan to investigate this issue. We have previously 
reported that 58 clones expressing C. pneumoniae ORFs are 
antigens using serum samples obtained from C. pneumoniae-
infected patients as the primary antibodies [21]. Thus, we 
examined the immunoreactivities of CPj0783 and revealed 
that C. pneumoniae definitely produced CPj0783 during 
infection; this molecule was recognized by three types of 
immunoglobulins, IgA, IgM and IgG, derived from hosts who 
suffered from primary acute C. pneumoniae infection. These 
results suggest that CPj0783 could be secreted out of the 
infected cells or released from the extruded inclusion and/or 
lysis of the host cell, and then the host immune system could 
recognize CPj0783 and produce specific antibodies. Based on 
these data, we chose CPj0783 and investigated it in detail.
It is thought that C. pneumoniae exchanges its morphology 
from RB to EB at approximately 48 h post-infection. The 
MOMP expression level increased depending on the number 
of C. pneumoniae cells without being affected by the C. pneu­
moniae cell cycle. The protein expression of CPj0783 was 
detected during the period of 24 h to 66 h post-infection and 
its peak expression occurred in 48 h post-infection. Then 
it rapidly decreased. Immunostaining of C. pneumoniae-
infected cells showed the presence of CPj0783 on chlamydial 
inclusions. These data suggest that CPj0783 might be 
generated in RBs, but not EBs, and would be necessary for 
growth in the inclusion body.
To investigate the function of CPj0783, we performed 
yeast two-hybrid screening and identified the CPj0783-
interacting protein. Using amino acids 25–262 of CPj0783 as 
bait, we found positive clones containing amino acids 8–182 
of HIP14. To confirm the interaction between CPj0783 and 
HIP14 in yeast cells, we exchanged the DNAs in the bait 
and prey used in the initial screening and found a positive 
interaction between the two. In addition, we used the total 
HIP14 cytoplasmic region (amino acids 1–303) as prey and 
still obtained a positive interaction with CPj0783 in yeast 
cells. By using an in vivo co-immunoprecipitation assay, we 
investigated the interaction between CPj0783 and HIP14. 
It was reported that HIP14 localized to the Golgi apparatus 
and cytoplasmic vesicles [6,7]. We made four types of HIP14 
constructs; N-terminal GFP- or mCherry-tagged HIP14 and 
C-terminal GFP- or mCherry-tagged HIP14. We found that 
all four types of HIP14 recombinants localized to the Golgi 
apparatus without any influence from the tagging molecules 
(data not shown). Then, subcellular localizations of Cpj0783 
and HIP14 were examined by immunostaining, both of which 
were confirmed to be present in the Golgi apparatus. It was also 
demonstrated that HIP14 could be co-immunoprecipitated 
with CPj0783 in vivo (Fig. 5A) and the interaction between 
CPj0783 and HIP14 was also found by an in vitro GST-pull 
down assay (Fig. 5C). These results demonstrably indicate 
that CPj0783 interacted with HIP14. Recently, it has been 
reported that the palmitoylation and distribution of HTT are 
regulated by the palmitoyl transferase of HIP14 [1,12,18]. 
There are multiple key functional domains identified: the 
ankyrin repeat domain in its N-terminal half (amino acids 
1–303) and the DHHC-palmitoyl acyl transferase domain 
and six transmembrane regions in its C-terminal half (amino 
acids 304–632) [15]. According to the results obtained from 
the yeast two-hybrid screening and the in vivo and in vitro 
binding assays, CPj0783 can interact with a part of the HIP14 
ankyrin repeat.
In this study, we focused on one of the C. pneumoniae 
proteins, CPj0783, which caused an intracellular trafficking 
abnormality in yeast cells. CPj0783 was detected by 
immunoglobulins derived from C. pneumoniae-infected 
patients and was certainly recognized by human immune 
cells. After the infection, CPj0783 might be generated in 
RBs and then transported in host cells to the Golgi apparatus 
where CPj0783 interacted with HIP14. The immunostaining 
assay could not reveal the existence of CPj0783 in the Golgi 
apparatus in C. pneumoniae-infected cells but did find 
CPj0783 on the inclusion bodies. As shown in the case of 
CPj0186/IncA, the molecule on the inclusion could interact 
with SNAREs localized to various intracellular organelles and 
membranes in human cells, and it caused the CPY mis-sorting 
in yeast cells [14]. In the case of C. trachomatis infection, 
the bacteria hijack the conserved oligomeric Golgi (COG) 
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complex, which is orchestrating the vesicular trafficking 
in the Golgi apparatus. Interaction of COG complex with 
chlamydial inclusion has been observed with C. trachomatis 
and this interaction was maintained throughout the entire 
development cycle [13]. It has not been yet clarified what 
molecules on the inclusion could recruit COG complex. After 
recruitment of COG complex to the inclusion, CPj0783, 
expressed on the inclusion, could contact with HIP14. In the C. 
pneumoniae-infected patients, CPj0783 might be translocated 
from the inclusion into host cells and subsequently induce 
the immunological response in human body [21]. It can be 
speculated that all molecules of CPj0783 expressed in RB 
do not translocate into host cells and that the translocated 
CPj0783 cannot be detected by immunostaining. Future work 
will be needed to further define the subcellular localization 
by more sensitive means of detection. Further studies on 
the function of CPj0783 in the C. pneumoniae infected cells 
are warranted, especially with regards to its function in the 
vesicle sorting machinery, which includes HIP14.
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